Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARTEMIS AF loading study
NL-OMON36400Phase 4Active, not recruiting
- Sponsor
- Sanofi
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of dronedarone and amiodarone in Atrial fibrillation (AFib) (3 arms), sponsored by Sanofi. Primary endpoint: Rate of atrial fibrillation recurrence at 1 month. Started Nov 2010; status: active, not recruiting.
02
Drugs
dronedaroneamiodarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NL-OMON36400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36400.